Adderall XR, Adderall IR, and Mydayis are all different formulations of amphetamine-based medications used to treat attention deficit hyperactivity disorder (ADHD). Each of these formulations contains different ratios of amphetamine salts, which can result in variations in dosage equivalencies.
Mydayis is a once-daily extended-release formulation of amphetamine salts. It provides a combination of immediate-release and delayed-release beads to provide a longer duration of action throughout the day. In contrast, Adderall XR is also an extended-release formulation, but it contains different proportions of amphetamine salts compared to Mydayis. Adderall IR, on the other hand, is an immediate-release formulation designed to be taken multiple times throughout the day.
The exact dosage equivalency between Mydayis and Adderall XR/IR can vary depending on individual patient factors and should be determined by a qualified healthcare professional. Equivalency ratios are not always straightforward and require careful consideration of the patient's response to the medications.
It's essential to follow your doctor's prescription and not make any changes to your medication or dosage without consulting them first. They will be best equipped to adjust dosages or switch formulations based on your specific needs and response to the medication. If you have concerns about your medication or its effectiveness, be sure to discuss them with your healthcare provider.